Cargando…

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii

INTRODUCTION: The efficacy of adjunctive therapy with cefoperazone-sulbactam (CEP-SUL) for ventilator-associated pneumonia (VAP) due to carbapenem-resistant A. baumannii (CRAB) is unclear. METHODS: We retrospectively analyzed the therapeutic effect of adding CEP-SUL to standard regimens for VAP due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanchanasuwan, Siripen, Kositpantawong, Narongdet, Singkhamanan, Kamonnut, Hortiwakul, Thanaporn, Charoenmak, Boonsri, Ozioma F, Nwabor, Doi, Yohei, Chusri, Sarunyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018428/ https://www.ncbi.nlm.nih.gov/pubmed/33824595 http://dx.doi.org/10.2147/IDR.S305819

Ejemplares similares

Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Bacteremia
por: Kanchanasuwan, Siripen, et al.
Publicado: (2022)

Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia
por: Kositpantawong, Narongdet, et al.
Publicado: (2021)

Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021
por: Sila, Thanit, et al.
Publicado: (2022)

Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP
por: Tongsengkee, Nonthanat, et al.
Publicado: (2023)

Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales
por: Pudpong, Korawan, et al.
Publicado: (2022)

Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem–Resistant Acinetobacter baumannii
por: Nwabor, Ozioma F., et al.
Publicado: (2021)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms
por: Nwabor, Lois Chinwe, et al.
Publicado: (2023)

Whole-genome analysis of carbapenem-resistant Acinetobacter baumannii from clinical isolates in Southern Thailand
por: Chukamnerd, Arnon, et al.
Publicado: (2022)

1724 Clinical Presentations and Interactions of the Chikungunya Viral Infection in HIV Patients During the Chikungunya Epidemic in Southern Thailand
por: Kositpantawong, Narongdet, et al.
Publicado: (2014)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
por: Niu, Tianshui, et al.
Publicado: (2019)

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates
por: Ontong, Julalak C., et al.
Publicado: (2021)

Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)
por: Terbtothakun, Pawarisa, et al.
Publicado: (2021)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
por: Islek, Ismail, et al.
Publicado: (2003)

Cefoperazone-Sulbactam Associated Refractory Seizures
por: Chovatiya, Harshad, et al.
Publicado: (2021)

Cefoperazone/sulbactam-induced hemolytic anemia
por: Sun, XM, et al.
Publicado: (2023)

BacSeq: A User-Friendly Automated Pipeline for Whole-Genome Sequence Analysis of Bacterial Genomes
por: Chukamnerd, Arnon, et al.
Publicado: (2023)

A Bibliometric Meta-Analysis of Colistin Resistance in Klebsiella pneumoniae
por: Nwabor, Ozioma Forstinus, et al.
Publicado: (2021)

In vitro Synergistic Activities of Fosfomycin in Combination with Other Antimicrobial Agents Against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) on the IncN2 Plasmid and a Study of the Genomic Characteristics of These Pathogens
por: Kaewnirat, Kalyarat, et al.
Publicado: (2022)

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Hu, Guangxue, et al.
Publicado: (2022)

In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
por: Sheu, Ming-Jen, et al.
Publicado: (2020)

Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
por: Zhou, Ling, et al.
Publicado: (2019)

Comparison of different ratios of cefoperazone/sulbactam in patients with pyelonephritis
por: Jiang, Weizhong, et al.
Publicado: (2023)

Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder
por: Miao, Wan, et al.
Publicado: (2023)

Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
por: Niu, Tianshui, et al.
Publicado: (2018)

The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection
por: Xiong, Zezhong, et al.
Publicado: (2022)

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam
por: Qu, Yan-Jing, et al.
Publicado: (2016)

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
por: Choi, Jun Yong, et al.
Publicado: (2006)

Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa
por: Tang, Xi-kang, et al.
Publicado: (2022)

Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
por: Ding, Peng, et al.
Publicado: (2022)

Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin
por: Sangthawan, Pornpen, et al.
Publicado: (2021)

Kinetics of Chikungunya Infections during an Outbreak in Southern Thailand, 2008–2009
por: Chusri, Sarunyou, et al.
Publicado: (2014)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
por: Xin, Xiaojuan, et al.
Publicado: (2013)

Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review
por: Wang, Zi, et al.
Publicado: (2021)

Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature
por: Kogilathota Jagirdhar, Gowthami Sai, et al.
Publicado: (2023)

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter baumannii-Associated Skin and Soft Tissue Infections
por: Wintachai, Phitchayapak, et al.
Publicado: (2022)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
por: Wang, Xueting, et al.
Publicado: (2023)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Multiple Cutaneous Nodules in an HIV-Infected Patient
por: Phumee, Atchara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kkgpfgdosfget71c80170vlscb